Palatin Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Corporate Update
Phase 3 Pivotal Study of PL9643 in Patients with Dry Eye Disease Ongoing Positive Interim Analysis – DMC Recommended Study Sample Size of 350 Patients Topline...
Source: prnewswire.com